KIMBERLY GARLAND: Open Payments
NPI 1104154137 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 112 payments from 17 companies in 2025. Trend: 2023 $1,381 · 2024 $1,838 · 2025 $2,342
Food & beverage: $2,265Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $309 |
| PFIZER INC. | 13 | $304 |
| Janssen Biotech, Inc. | 14 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $183 |
| Ardelyx, Inc. | 5 | $161 |
| Regeneron Healthcare Solutions, Inc. | 6 | $158 |
| Celltrion USA Inc. | 8 | $151 |
| Madrigal Pharmaceuticals | 7 | $150 |
| Phathom Pharmaceuticals, Inc. | 8 | $132 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $101 |
Products named: TREMFYA, DUPIXENT, XELJANZ, IBSRELA, VEGZELMA, REZDIFFRA, ENTYVIO, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
